Entity

Time filter

Source Type

Seattle, WA, United States

Patent
Immune Design | Date: 2014-07-17

The present disclosure relates generally to compositions and methods for treating cancer with a glucopyranosyl lipid A (GLA) in the absence of antigen.


Patent
Immune Design | Date: 2015-01-08

The present disclosure relates generally to compositions and methods for treating cancer with a glucopyranosyl lipid A (GLA) in the absence of antigen.


Patent
Immune Design | Date: 2015-08-26

The present disclosure relates generally to compositions and methods for treating cancer with a glucopyranosyl lipid A (GLA) in the absence of antigen.


Compositions and methods are provided herein for improved dual immunization strategies that induce in a subject an immune response that includes a humoral immune response and cellular immune response, both CD4 and CD8 T lymphocyte immune responses, thereby providing a complete adaptive immune response to one or more antigens. The methods described are therefore useful for treating and/or preventing (i.e., reducing the likelihood or risk of occurrence) different diseases, disorders, and conditions such as cancers and infectious diseases for which induction of both a humoral immune response and cellular immune response is desired and beneficial.


Patent
Immune Design | Date: 2015-01-20

Compositions and methods are provided herein for treatment of allergic conditions, by administration of an adjuvant composition, with or without allergen.

Discover hidden collaborations